email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

ISSN: 2644-1306

Theranostics of Respiratory & Skin Diseases

Research Article(ISSN: 2644-1306)

Interactions between Measles, Mumps and Rubella (Mmr) Vaccines and Atopic Diseases in Children

Volume 1 - Issue 1

Jacques Lukenze Tamuzi*1 and Jonathan Lukusa Tshimwanga2

  • Author Information Open or Close
    • 1Community Health Division, Faculty of Medicine and Health Sciences, Stellenbosch University, Matieland, South Africa
    • 2Division of Family medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Matieland, South Africa

    *Corresponding author: Jacques Lukenze Tamuzi, Community Health Division, Faculty of Medicine and Health Sciences, Stellenbosch University, Matieland, South Africa

Received: February 15, 2018;   Published: February 27, 2018

DOI: 10.32474/TRSD.2018.01.000101

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Background: Epidemiologic data on atopic diseases are scared. Different studies have shown that the burden of atopic diseases is varying in space and time. Several factors are impacting on epidemiology of atopic in children. Among them, MMR vaccination has been a topic of divergences.

Objective: To establish whether the MMR vaccination may influence the risk of atopic diseases in children.

Methods: We conducted electronic search terms included MESH or key words with “Atopic diseases” and “MMR vaccination” and “Children”. Databases for peer-reviewed articles included Pub Med, CENTRAL, Scopus and CINAHL Plus. Additionally, Grey literature was obtained from Google and WHO database.

Main results: Among 304 potentially relevant articles identified, 8 peer-reviewed articles met the inclusion criteria. Due to the lack of standardized reporting of different outcomes and different study designs, we reported the results narratively based on P-value and 95% CI. We found three studies that demonstrated that MMR vaccination increased the fold of asthma in children (P<0.05). In contrast, two studies have approved that MMR vaccination is benefit in preventing asthma in children. MMR vaccination decreases asthma respectively by OR 0.36 95%CI (0.14-0.91) and OR 0.96 95% CI (0.76-1.21). Two studies reported MMR vaccination increase the eczema OR in two studies with respectively OR: 1.77 95% CI (1.20-2.61) and OR 1.86 95%CI (1.25-2.79). On the other hand, three studies revealed that MMR vaccination did not have any effect on atopic eczema with respectively P=0.830, OR 0.94 95% CI (0.77-1.15) and P=0.90.

Conclusion: Based on the variability between studies, we hypothesize that judging the association between MMR vaccination and atopic diseases could not be fruitful in understanding different mechanisms. In this context, we suggested the interactions between Gene-environment MMR vaccination and atopic diseases that could clarify divergences between the results.

Keywords: Atopic diseases; MMR vaccination; Children

Abstract| Background| Objective| Methods| Results| Discussion and Conclusion| References|

Close

Online Submission System

Drag and drop files here

or

Browse Files
( For multiple files submission, zip them in a single file to submit. For file zipping software Download )